Simplex Trading’s Windtree Therapeutics Inc WINT Stock Holding History

Simplex Trading’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-276	Closed	-$54K	–	7270
2017 Q2	$54K	Buy	276 +176	+176%	+$205	﹤0.01%	2339
2017 Q1	$1K	Buy	+100	New	+$130	﹤0.01%	6006
2015 Q2	–	Sell	-9	Closed	-$1K	–	6303
2015 Q1	$1K	Buy	9 +4	+80%	+$79	﹤0.01%	4769
2014 Q4	$1K	Buy	+5	New	+$110	﹤0.01%	4472

Other funds holding WINT

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Simplex Trading's WINT Position: Q4 2016 in Review

Simplex Trading sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 2,895 shares — an estimated $5.35K sold.

Simplex Trading first reported a position in WINT in Q1 2015 and held it in 4 quarters. The position peaked at $16K in Q1 2015. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

Simplex Trading reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
Simplex Trading sold 2,895 Windtree Therapeutics Inc shares in Q4 2016, an estimated $5.35K.
Simplex Trading first reported a position in Windtree Therapeutics Inc in Q1 2015 and held it in 4 quarters.
Simplex Trading's Windtree Therapeutics Inc position peaked at $16K in Q1 2015.
31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.